Linear IgA bullous dermatosis (LABD), also known as linear IgA dermatosis, is a rare immune-mediated disease that results in blistering of the skin, in the subepidermal layers. It is commonly ...

Here, we describe a patient with non-Hodgkin's lymphoma who developed LABD after autologous HSCT and was successfully treated with glucocorticoid, dapsone and high-dose i.v. Ig, but the lymphoma ...

BP can bear close resemblance to a variety of dermatoses including localized or generalized drug reactions, contact and allergic dermatitis, urticarial vasculitis, arthropod reactions, scabies, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 26-month-old boy presented for evaluation of acute ...

Background: Bullous autoimmune dermatoses are a clinically and immunopathologically heterogeneous group of diseases, characterized clinically by blisters or erosions of the skin and/or mucous ...

The ambiguous and contradictory data published on a number of the vesiculobullous autoimmune diseases is due to a number of reasons, including: the rarity of certain diseases; changing criteria for ...

We describe a novel autoimmune disease characterized by severe subepidermal bullous eruption and crescentic glomerulonephritis with autoantibodies directed against the noncollagenous domain of the α5 ...

WARSAW, Poland--(BUSINESS WIRE)--JJP Biologics, a company that specializes in the development of proprietary biologic agents for personalized medicine approaches, has announced that the European ...

Direct immunofluorescence (DIF) microscopy showed a 15.5% positivity rate in pediatric patients and changed the clinical diagnosis in 16.7% of those cases. Researchers conducted a retrospective review ...

A 55-year-old man presents to the clinic with multiple tense bullae diffusely involving his trunk and extremities that overlie urticarial plaques. The patient states that for the past 4 weeks, his ...

Antagonist anti-CD89 will be developed for the treatment of Linear IgA Bullous Dermatosis. WARSAW, Poland — JJP Biologics, a company that specializes in the development of proprietary biologic agents ...